SP
Sanjiv Patel (President and CEO) filed 5 Form 4 reports in the trailing twelve months (0 purchases, 5 sales), most often in Relay Therapeutics, Inc. (RLAY). The largest single filing was $980K of RLAY (48,199 sh × $20.33, as filed), executed Aug 17. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
5
0 buys · 5 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$4.0M
shares × price, as filed
Last traded
Oct 7
Filed Oct 8
Median ADV $74.0M across their filed names
Open performance→Volume by month
Buys $0
Sells $7.8M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
5 filings
Sector per market data · by filing · past 12 months
Most traded names
RLAYRecent filings
RLAYSALE
Relay Therapeutics, Inc.
View filing →
$818K215,506 sh across 2 lots
Exec Feb 11 2025
Filed Feb 13 2025 · 5:30 PM ET RLAYSALE Relay Therapeutics, Inc. View filing → $1.8M
375,000 sh across 3 lots
Exec Jan 21 2025
Filed Jan 23 2025 · 5:30 PM ET RLAYSALE Relay Therapeutics, Inc. View filing → $500K
100,000 sh × $5.00
Exec Dec 16 2024
Filed Dec 18 2024 · 5:30 PM ET